OCUL
Ocular TherapeutixCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
OCUL vs peer average
61/100
OCUL vs. peer average (C vs. D)
Grade spread
A 1 · B 2 · C 1 · D 1 · F 5
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
EYPT is the first available peer comparator.
EyePoint Pharmaceuticals — small-cap ocular therapeutics with commercial-stage product and event-driven financing history.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
OCUL
Ocular Therapeutix
EYPT
EyePoint
Grade
C
C
Momentum
15
27
Value
41
41
Sentiment
98
79
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Mixed
Grade position vs EYPT
OCUL / EYPT
Grade Position
In line
OCUL vs. peer average (C vs. D)
61/100
Momentum
15
EYPTValue
41
OCULSentiment
98
OCULRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs OCUL
EYPT is the first peer returned for this comparison set.